How much do you know about OncoDNA?
Test Your Knowledge on OncoDNA
Are you ready to learn more about OncoDNA and its innovative approaches to cancer theranostics? This quiz challenges your knowledge and helps you discover fascinating facts about the company and its contributions to cancer treatment.
Join us and see how much you know!
- 12 engaging questions
- Learn about biomarker testing and liquid biopsy
- Discover OncoDNA's unique mission and achievements
Over the years, OncoDNA has developed a series of biomarker tests. What is biomarker testing?
Biomarker testing is a way to understand the molecular particularities of a tumor and identify the most effective treatment for a patient, or monitor disease progression.
Biomarker testing is a radiology test used to find out how far a cancer has spread and whether a treatment is working.
Biomarker testing is a series of symptoms that may indicate the development of a cancer.
OncoDEEP is OncoDNA’s flagship biomarker test. It is a comprehensive solution that screens for all the cancer markers (DNA, RNA and protein) present in a tumor tissue. Why does it matter?
Screening for all biomarkers in one single test helps identify relevant immunotherapy options.
Screening for all biomarkers in one single test helps identify clinical trial options.
Screening for all biomarkers in one single test increases the likelihood to identify all relevant cancer treatments (chemotherapy, immunotherapy, targeted therapy and hormone therapy; and potential clinical trial options) in a fast turnaround time.
Which company did OncoDNA acquire in 2017 as part of an effort to expand its presence in Europe and Latin America?
BioSequence
Oncovision
Oncogenomics
OncoDNA is also specializing in liquid biopsy testing. What is the potential of this promising technology?
Liquid biopsy is a fast and minimally invasive method to understand the reasons why a cancer developped.
Liquid biopsy is a fast and minimally invasive method to identify relevant treatment options and monitor disease progression in real time.
Liquid biopsy is a cost-effective method to predict the development of genetic diseases.
What is OncoDNA's mission?
To empower physicians, biopharma companies and researchers to create a world without cancer
To empower physicians, biopharma companies and researchers to make the best use of artificial intelligence
To empower physicians, biopharma companies and researchers to deliver the promise of precision medicine to patients living with cancer and genetic disease
Is OncoDNA present in the US?
No, it is not.
Yes, OncoDNA collaborates with a subcontracted lab in the US.
Yes, OncoDNA collaborates with a subcontracted lab and has an entity in the US.
{"name":"How much do you know about OncoDNA?", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"Are you ready to learn more about OncoDNA and its innovative approaches to cancer theranostics? This quiz challenges your knowledge and helps you discover fascinating facts about the company and its contributions to cancer treatment.Join us and see how much you know!12 engaging questionsLearn about biomarker testing and liquid biopsyDiscover OncoDNA's unique mission and achievements","img":"https:/images/course2.png"}
More Quizzes
Test Your Knowledge on Pancreatic Cancer and Gemcitabine
846
High-Risk Cytogenetics
11619
BTG Pharma Quiz July 2016
840
Clinical Trials Invoicing Centralization
1366
Biomedical Technology Quiz I
28140
Introduction Quiz
105475
Life4QuestionBankQuiz
9950136
AHA poll
840
Research 2
10573
The Proventa Challenge
14713
FMRI BOLD
12626
Survey about health care information exchange using blockchain and machine learning
16848